Improving the action of insulin.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Clinical and investigative medicine. Medecine clinique et experimentale

• Publication date

  1995-08-01

• Fields of study

  Medicine

• Identifiers
  PMID 8549022
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of cigarette smoking and of a transdermal nicotine delivery system on glucoregulation in type 2 diabetes mellitus

  2006cited by this paper
• Simvastatin reduces plasma lipid levels and improves insulin action in elderly, non-insulin dependent diabetics

  2004cited by this paper
• Therapy for obesity--today and tomorrow.

  1994cited by this paper
• Changes in glucose turnover parameters and improvement of glucose oxidation after 4-week magnesium administration in elderly noninsulin-dependent (type II) diabetic patients.

  1994cited by this paper
• Insulin secretion, clearance and action before and after gastroplasty in severely obese subjects.

  1994cited by this paper
• Effects of Benfluorex on Insulin Resistance and Lipid Metabolism in Obese Type II Diabetic Patients

  1993cited by this paper
• Effects of Metformin on Insulin Resistance, Risk Factors for Cardiovascular Disease, and Plasminogen Activator Inhibitor in NIDDM Subjects: A study of two ethnic groups

  1993cited by this paper
• Behavioral Treatment of Obesity: Its application to type II diabetes

  1993cited by this paper
• Pharmacological treatment of the obese diabetic patient.

  1993cited by this paper
• Influence of short-term dexfenfluramine therapy on glucose and lipid metabolism in obese non-diabetic patients.

  1993cited by this paper
• Magnesium deficiency produces insulin resistance and increased thromboxane synthesis.

  1993cited by this paper
• Insulin resistance and cigarette smoking.

  1992cited by this paper
• The Effect of Etomoxir on Insulin Sensitivity in Type 2 Diabetic Patients

  1992cited by this paper
• New Pharmacological Approaches to Therapy of NIDDM

  1992cited by this paper
• Biguanides and NIDDM

  1992cited by this paper
• Metformin Normalizes Nonoxidative Glucose Metabolism in Insulin-Resistant Normoglycemic First-Degree Relatives of Patients With NIDDM

  1992cited by this paper
• Fluoxetine increases insulin action in obese nondiabetic and in obese non-insulin-dependent diabetic individuals.

  1992cited by this paper
• Rationale and Application of Fatty Acid Oxidation Inhibitors in Treatment of Diabetes Mellitus

  1992cited by this paper
• New Oral Thiazolidinedione Antidiabetic Agents Act as Insulin Sensitizers

  1992cited by this paper
• Effects of prolonged Acipimox treatment on glucose and lipid metabolism and on in vivo insulin sensitivity in patients with non-insulin dependent diabetes mellitus.

  1992cited by this paper
• Metabolic Effects of New Oral Hypoglycemic Agent CS-045 in NIDDM Subjects

  1992cited by this paper
• Metabolic Effects of Suppression of Nonesterified Fatty Acid Levels With Acipimox in Obese NIDDM Subjects

  1992cited by this paper
• Effect of Antihypertensive Drugs on Insulin, Glucose, and Lipid Metabolism

  1991cited by this paper
• ACE-inhibition increases hepatic and extrahepatic sensitivity to insulin in patients with Type 2 (non-insulin-dependent) diabetes mellitus and arterial hypertension

  1991cited by this paper
• Prevention of Type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise The 6-year Malmö feasibility study

  1991cited by this paper
• Benfluorex and blood glucose control in non insulin-dependent diabetic patients

  1991cited by this paper
• Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus.

  1991cited by this paper
• Drug Treatment of Hypertension in Patients With Diabetes Mellitus

  1991cited by this paper
• Improvement of Insulin-Induced Glucose Disposal in Obese Patients With NIDDM After 1-Wk Treatment With d-Fenfluramine

  1991cited by this paper
• Magnesium and glucose homeostasis

  1990cited by this paper
• Cellular Mechanism of Action of Metformin

  1990cited by this paper
• Improved Insulin Response and Action by Chronic Magnesium Administration in Aged NIDDM Subjects

  1989cited by this paper
• Fenfluramine Increases Insulin Action in Patients With NIDDM

  1989cited by this paper
• The impact of obesity on the pathogenesis of non-insulin-dependent diabetes mellitus: a review of current hypotheses.

  1989cited by this paper
• Insulin resistance and noninsulin-dependent diabetes mellitus: which horse is pulling the cart?

  1989cited by this paper
• Management of Non‐insulin‐dependent Diabetes Mellitus in Europe: A Concensus View

  1988cited by this paper
• Impaired insulin-induced erythrocyte magnesium accumulation is correlated to impaired insulin-mediated glucose disposal in Type 2 (non-insulin-dependent) diabetic patients

  1988cited by this paper
• Following weight loss in massively obese patients correction of the insulin resistance of fat metabolism is delayed relative to the improvement in carbohydrate metabolism.

  1988cited by this paper
• Banting lecture 1988. Role of insulin resistance in human disease.

  1988cited by this paper
• Obesity and insulin resistance: lessons learned from the Pima Indians.

  1988cited by this paper
• Regulation of glucose storage in obesity and diabetes: metabolic aspects.

  1988cited by this paper
• Effects of hypocaloric diet and insulin therapy on metabolic control and mechanisms of hyperglycemia in obese non-insulin-dependent diabetic subjects.

  1988cited by this paper
• Insulin Action in Obese Non-Insulin-Dependent Diabetics and in Their Isolated Adipocytes Before and After Weight Loss

  1987cited by this paper
• Metformin Decreases the High Plasminogen Activator Inhibition Capacity, Plasma Insulin and Triglyceride Levels in Non-Diabetic Obese Subjects

  1987cited by this paper
• Effects of weight loss in massive obesity on insulin and C-peptide dynamics: sequential changes in insulin production, clearance, and sensitivity.

  1987cited by this paper
• Glucose tolerance and smoking: A population study of oral and intravenous glucose tolerance tests in middle-aged men

  1983cited by this paper
• [Effect of benfluorex on the metabolic fate of an oral glucose load in obese subjects with reduced glucose tolerance (author's transl)].

  1979cited by this paper
• Insulin binding to monocytes and insulin action in human obesity, starvation, and refeeding.

  1978cited by this paper
• The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus.

  1963cited by this paper

• Mineral Composition, Phenolic Content, and In Vitro Antidiabetic and Antioxidant Properties of Aqueous and Organic Extracts of Haloxylon scoparium Aerial Parts

  2021cites this paper
• Hypomagnesemia As A Marker Of Diabetic Nephropathy

  2018cites this paper
• Study of serum magnesium levels in diabetes mellitus and its correlation with complications (retinopathy and HbA1c) a cross-sectional study of one year

  2017cites this paper
• Hydrothermal Duodenal Mucosal Resurfacing: Role in the Treatment of Metabolic Disease.

  2017cites this paper
• Mineral Salt Composition and Secondary Metabolites of Ocimum gratissimum L., An Anti-hyperglycemic Plant

  2016cites this paper
• Study of Association of Serum Magnesium with Diabetes Mellitus at a Tertiary Care Teaching Centre

  2016cites this paper
• The Study of Correlation between Serum Magnesium Level and Diabetic Retinopathy in Rural Population

  2015cites this paper
• Minerals salt composition and secondary metabolites of Euphorbia hirta Linn., an antihyperglycemic plant

  2015cites this paper
• Amino acids and proteins for the athlete

  2014cites this paper
• The Impact of Magnesium on Isometric Twitch Parameters and Resting Membrane Potential of the Skeletal Muscle in Diabetic Rats

  2013cites this paper
• SERUM MAGNESIUM AS A MARKER OF DIABETIC COMPLICATIONS

  2012cites this paper
• Status of serum magnesium in type 2 diabetes mellitus with particular reference to serum triacylglycerol levels.

  2012cites this paper
• Prevention of Type 2 Diabetes Mellitus Through Inhibition of the Renin-Angiotensin System

  2012cites this paper
• Is There a Role for α-Glucosidase Inhibitors in the Prevention of Type 2 Diabetes Mellitus?

  2012cites this paper
• THE EFFECT OF MAGNESIUM TREATMENT ON PASSIVE–AVOIDANCE RESPONSE AND FORMAIN TEST IN DIABETIC RATS

  2010cites this paper
• Fatty Acid Metabolism in Diabetes

  2007cites this paper
• Getting It Together

  2007cites this paper
• Physiological and Behavioral Aspects of Glycemic Control and Hypoglycemia in Diabetes

  2007cites this paper
• EFFECTS OF METFORMIN IN INSULIN – TREATED TYPE 2 DIABETES MELLITUS PATIENTS

  2005cites this paper
• Pioglitazone increases serum magnesium levels in glucose-intolerant subjects. A randomized, controlled trial.

  2003cites this paper
• Is there a role for alpha-glucosidase inhibitors in the prevention of type 2 diabetes mellitus?

  2003cites this paper
• Oral combination therapy for type 2 diabetes

  2002cites this paper
• PRÉVENTION DE L'APPARITION DU DIABÈTE DE TYPE 2 PAR L'INHIBITION DU SYSTÈME RÉNINE-ANGIOTENSINE

  2002cites this paper
• Prevention de l'apparition du diabete de type 2 par l'inhibition du systeme renine-angiotensine.

  2002cites this paper
• [The insulin sensitivity concept].

  2001cites this paper
• LE CONCEPT D'INSULINOSENSIBILITÉ

  2001cites this paper
• Hypomagnesemia is linked to low serum HDL-cholesterol irrespective of serum glucose values.

  2000cites this paper
• Effects of metformin in patients with poorly controlled, insulin-treated type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial.

  1999cites this paper
• Effects of Metformin in Patients with Poorly Controlled, Insulin-Treated Type 2 Diabetes Mellitus

  1999cites this paper
• Glucose metabolism and the postprandial state

  1999cites this paper
• Aggressive weight reduction treatment in the management of type 2 diabetes.

  1998cites this paper
• Oral Antidiabetic Agents

  1998cites this paper
• Novel therapeutic strategies for the treatment of type 2 diabetes.

  1998cites this paper
• Perspective in the treatment of insulin resistance.

  1997cites this paper
• Drug Treatment of Non-Insulin-Dependent Diabetes Mellitus in the 1990s

  1997cites this paper
• Centro de química farmacéutica tiazolidinadionas: una nueva familia de hipoglicemiantes orales

  1997cites this paper
• Insulin resistance syndrome and atherosclerotic cardiovascular disease.

  1996cites this paper
• International Journal of Biological & Medical Research Study of Serum Magnesium in Diabetic Retinopathy

  year unknowncites this paper